Montelukast Prescribing at AMPLEFORTH SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
778
Total Quantity
19.9K
NHS Cost
£997
vs National Avg
+13.6%
AMPLEFORTH SURGERY prescribed 778 items of Montelukast over the last 12 months at a cost of £997 to the NHS. This is 13.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
66
Jun 2026
71
Jun 2026
72
Jun 2026
53
Jun 2026
66
Jun 2026
72
Jun 2026
68
Jun 2026
60
Jun 2026
60
Jun 2026
68
Jun 2026
63
Jun 2026
59
Prescribing Details
| Total Items | 778 |
|---|---|
| Total Quantity | 19,889 |
| Total NHS Cost | £997 |
| Presentations | 4 different forms |
| vs National Average | +13.6% |
Montelukast Prescribing Comparison
| This practice | 778 items |
|---|---|
| National average per practice | 685 items |
| Difference | +13.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.